Stockscreener 앱 받기
138.05
0.22%
0.2488
전일 마감가:
$138.30
열려 있는:
$134.91
하루 거래량:
156.62K
Relative Volume:
0.27
시가총액:
$3.98B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-44.39
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
+0.83%
1개월 성능:
+17.21%
6개월 성능:
+106.17%
1년 성능:
+84.42%
1일 변동 폭
$134.00
$139.80
1주일 범위
$128.75
$144.79
52주 변동 폭
$55.17
$146.00
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
WGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
138.66 | 4.00B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
564.71 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.00 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.58 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.94 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.82 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-05-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
모두보기
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Corton Capital Inc. Invests $339,000 in GeneDx Holdings Corp. $WGS - MarketBeat
Key metrics from GeneDx Holdings Corp. Equity Warrant’s quarterly dataEarnings Beat & Low Drawdown Investment Strategies - newser.com
Can GeneDx Holdings Corp. stock deliver surprise earnings beatJobs Report & Growth Focused Investment Plans - newser.com
Real time pattern detection on GeneDx Holdings Corp. Equity Warrant stockFed Meeting & Daily Chart Pattern Signal Reports - newser.com
GeneDx Holdings Corp. $WGS Shares Sold by Hussman Strategic Advisors Inc. - MarketBeat
What moving averages say about GeneDx Holdings Corp. Equity WarrantJuly 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
Price action breakdown for GeneDx Holdings Corp. Equity Warrant2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Volume spikes in GeneDx Holdings Corp. stock – what they mean2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Visual trend scoring systems applied to GeneDx Holdings Corp. Equity WarrantMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
How rising interest rates impact GeneDx Holdings Corp. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Will GeneDx Holdings Corp. Equity Warrant stock outperform international peersWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com
Why GeneDx Holdings Corp. stock could be next big winnerForecast Cut & Technical Pattern Recognition Alerts - newser.com
Will GeneDx Holdings Corp. Equity Warrant stock continue dividend increasesJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
How high can GeneDx Holdings Corp. stock go2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
GeneDx Holdings Corp. stock prediction for this weekGlobal Markets & High Return Stock Watch Alerts - newser.com
Will GeneDx Holdings Corp. stock maintain growth storyTrade Signal Summary & Technical Pattern Alert System - newser.com
Heatmap analysis for GeneDx Holdings Corp. and competitorsMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Zweig DiMenna Associates LLC Buys 129,000 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Should you hold or exit GeneDx Holdings Corp. Equity Warrant nowJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Kovack Advisors Inc. Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat
Can momentum traders help lift GeneDx Holdings Corp. Equity Warrant2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Is GeneDx Holdings Corp. stock a top pick in earnings seasonJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Oppenheimer Asset Management Inc. Invests $236,000 in GeneDx Holdings Corp. $WGS - MarketBeat
Will GeneDx Holdings Corp. stock split again soonJuly 2025 Intraday Action & Community Consensus Stock Picks - newser.com
How GeneDx Holdings Corp. Equity Warrant stock performs in rising dollar environment - newser.com
Can momentum traders help lift GeneDx Holdings Corp.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
GeneDx Holdings (WGS) Is Up 6.2% After Raised Guidance and FDA Breakthrough Designation – What's Changed - simplywall.st
Can GeneDx Holdings Corp. stock resist market sell offsWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Will GeneDx Holdings Corp. stock outperform tech sector in 2025Quarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
Wall Street Zen Downgrades GeneDx (NASDAQ:WGS) to Hold - MarketBeat
GeneDx (NASDAQ:WGS) CFO Sells $52,977.52 in Stock - MarketBeat
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 2,158 Shares - MarketBeat
Is GeneDx Holdings Corp Equity Warrant a good long term investmentEarnings Forecast Updates & Outstanding Return Stocks - earlytimes.in
Price action breakdown for GeneDx Holdings Corp.Weekly Trend Report & Fast Entry High Yield Tips - newser.com
Jennison Associates LLC Has $36.73 Million Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Genedx Holdings Corp 주식 (WGS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Oct 29 '25 |
Sale |
136.54 |
2,158 |
294,654 |
3,436 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Oct 29 '25 |
Option Exercise |
0.00 |
753 |
0 |
4,145 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Oct 29 '25 |
Sale |
136.54 |
388 |
52,978 |
3,757 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 30 '25 |
Sale |
108.17 |
12,858 |
1,390,911 |
1,720 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
10,001 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Sale |
108.38 |
6,609 |
716,261 |
3,392 |
0.93%
6.67%
자본화:
|
볼륨(24시간):